NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Severe Combined Immunodeficiency


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Findings from M. Malphettes and co-researchers advance knowledge in common variable immunodeficiency
2009 NOV 24 ... decrease in CD4(+) T cell counts (158 x 10(6) vs 604 x 10(6) cells/L; P<.001) and a severe defect in naive CD45RA(+)CCR7(+)CD4(+) T cell counts (<20% of total CD4(+) T cells in ... risk for OIs. Among 313 patients with CVID, 28 patients (8.9%) presented with late-onset combined immune deficiency (LOCID), defined by the occurrence of an OI and/or a CD4(+) T cell ... According to a study from Paris, France, "Common variable immunodeficiency (CVID) is a primary immune deficiency defined by defective antibody production. In most ...
Subject: Common Variable Immunodeficiency
Price: $3.00
*
Investigators at Shinshu University, Medical Department publish new data on leukemia gene therapy
2009 NOV 16 ... we identified a HIR in a similar region as the TPA-Mat T cell line. One of the X-linked severe combined immunodeficiency (X-SCID) patients that developed leukemia after gene therapy had a vector integration ...
Subject: Leukemia Gene Therapy
Price: $3.00
*
New mental disorders study findings have been published by D. Biljan and colleagues
2009 NOV 23 ... Dermatology, Diagnostics, Genetics, Mental Disorder, Mental Health, Psoriasis, Severe Combined Immunodeficiency. This article was prepared by Mental Health Weekly Digest editors from ...
Subject: Mental Disorders
Price: $3.00
*
New omenn's syndrome findings from Tel-Aviv University published
2009 NOV 23 ... Disease, Autoimmune Disorder, Clinical Immunology, DNA, Immunology, Omenn's Syndrome, Severe Combined Immunodeficiency, Tel-Aviv University. This article was prepared by Proteomics Weekly ...
Subject: Omenn's Syndrome
Price: $3.00
*
Reports summarize veterinary research study results from University of Guelph
2009 NOV 23 ... their susceptibility to the virus. No virus replication was detected in BALB/c or SCID (severe combined immunodeficiency) mice after intraperitoneal inoculation. Moderate replication of PRRSV was detected in ...
Subject: Veterinary Research
Price: $3.00
*
Research conducted at G. Bertolini and co-authors has provided new information about lung cancer
2009 NOV 16 ... Cancer, Lung Neoplasms, Oncology, Pharmaceuticals, Pulmonology, Respiratory Infection, Severe Combined Immunodeficiency, Stem Cell Research, Therapy, Treatment, Xenograft, Xenotransplantion. This ...
Subject: Lung Cancer
Price: $3.00
*
Research findings from G. Bentley et al update understanding of life sciences
2009 NOV 9 ... as by the detection of the rare nontransmitted maternal allele present in the blood of a severe combined immunodeficiency disease syndrome (SCIDS) patient." Bentley and colleagues published their ...
Subject: Life Sciences
Price: $3.00
*
Research from Kumamoto University broadens understanding of virology
2009 NOV 16 ... Immunology, Kinase, Nucleoside Reverse Transcriptase Inhibitor, Proteins, Proteomics, Severe Combined Immunodeficiency, Sexually Transmitted Disease, Therapy, Treatment, Viral, Virology, Kumamoto University. ...
Subject: Virology
Price: $3.00
*
Research from Umea University in borrelia provides new insights
2009 NOV 23 ... Country:Sweden, Borrelia, Borreliosis, Epidemics, Immunology, Relapsing Fever, Severe Combined Immunodeficiency, Tropical Disease, Umea University. This article was prepared by Malaria ...
Subject: Borrelia
Price: $3.00
*
Research from University of Cologne has provided new data on severe combined immunodeficiency
2009 NOV 16 ... Keywords: Germany, Cologne, Apoptosis, Bioengineering, Biotechnology, Cancer, Oncology, Severe Combined Immunodeficiency, Transplantation, Xenograft, Xenotransplantion, University of Cologne. This ...
Subject: Severe Combined Immunodeficiency
Price: $3.00
*
Research from Washington University has provided new data on personality disorders
2009 NOV 16 ... Mental Health, Narcissistic Personality Disorder, Pathology, Psychopathology, Severe Combined Immunodeficiency, Washington University. This article was prepared by Mental Health Weekly ...
Subject: Personality Disorders
Price: $3.00
*
Researchers at Princess Margaret Hospital release new data on myeloma
2009 NOV 9 ... addition, oral CPX prevented the engraftment of primary AML cells in nonobese diabetic/severe combined immunodeficiency mouse models, thereby establishing its ability to target leukemia stem cells. ...
Subject: Myeloma
Price: $3.00
*
Researchers from Monash University publish findings in brain injuries
2009 NOV 23 ... Depression, Major Depressive Disorder, Mental Health, Psychiatric Disorder, Psychiatry, Severe Combined Immunodeficiency, Monash University. This article was prepared by Mental Health Weekly ...
Subject: Brain Injuries
Price: $3.00
*
Researchers from Rush University provide details of new studies and findings in the area of inflammation
2009 NOV 23 ... State:IL, Country:United States, Antiinflammatory, Arthritis, Inflammation, Rheumatism, Severe Combined Immunodeficiency, Therapy, Treatment, Rush University. This article was prepared by Pain & ...
Subject: Inflammation
Price: $3.00
*
Researchers from Yeshiva University provide details of new studies and findings in the area of stem cell research
2009 NOV 16 ... of cells was analyzed in vivo after transplantation in xenotolerant nonobese diabetic/severe combined immunodeficiency mice through intrasplenic or intraportal routes. We found that adult hepatocytes and ...
Subject: Stem Cell Research
Price: $3.00
*
Roche Molecular Systems Research Team Uses 454 Sequencing System for High-Resolution HLA Genotyping
2009 NOV 9 ... able to detect rare variants, such as the non-transmitted maternal allele in a SCIDS [Severe Combined Immunodeficiency Syndrome] sample, reflecting the presence of maternal cells in the subject's ...
Subject: Roche Molecular Systems
Price: $3.00
*
Scientists at Purdue University target inflammation
2009 NOV 9 ... Crohn Disease, Gastroenterology, Gastrointestinal, Inflammation, Retinoic Acid, Severe Combined Immunodeficiency, Therapy, Treatment, Vitamin A, Vitamins (Vitamin A), Purdue University. ...
Subject: Inflammation
Price: $3.00
*
Studies from University of California yield new data on squamous cell carcinoma
2009 NOV 16 ... Design, Head and Neck Cancer, Head and Neck Carcinoma, Oncology, Pain Medicine, Severe Combined Immunodeficiency, Squamous Cell Carcinoma, Xenograft, Xenotransplantion, University of California. ...
Subject: Squamous Cell Carcinoma
Price: $3.00
*
Studies from X.L. Wang and co-researchers yield new data on myelofibrosis
2009 NOV 16 ... Box, Behavior, Cancer, Diabetes, Endocrinology, Hematology, Myelofibrosis, Oncology, Severe Combined Immunodeficiency. This article was prepared by Clinical Oncology Week editors from staff and ...
Subject: Myelofibrosis
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login